PipelineSTERNA BIOLOGICALS

Despite widespread corticosteroid use and the availability of biologicals, there is still an unmet need for safer, more efficacious anti-inflammatory treatments for chronic diseases.

sterna biologicals has completed multiple phase IIa clinical trials with topical formulations of hgd40 in a number of commercially attractive chronic inflammatory diseases with high unmet medical need.


Table with pipeline phases